Compare · EW vs PII
EW vs PII
Side-by-side comparison of Edwards Lifesciences Corporation (EW) and Polaris Inc. (PII): market cap, price performance, sector, and recent activity on the wire.
Summary
- EW operates in Health Care, while PII operates in Consumer Discretionary - the two are in different parts of the market.
- EW is the larger of the two at $52.38B, about 14.5x PII ($3.62B).
- EW has been more active in the news (3 items in the past 4 weeks vs 2 for PII).
- Both have 25 recent analyst ratings on file.
- Company
- Edwards Lifesciences Corporation
- Polaris Inc.
- Price
- $90.83+0.31%
- $63.56-1.20%
- Market cap
- $52.38B
- $3.62B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NYSE
- IPO
- News (4w)
- 3
- 2
- Recent ratings
- 25
- 25
Edwards Lifesciences Corporation
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Polaris Inc.
Polaris Inc. designs, engineers, manufactures, and markets power sports vehicles worldwide. It operates in five segments: ORV/Snowmobiles, Motorcycles, Global Adjacent Markets, Aftermarket, and Boats. The company offers off-road vehicles (ORVs), including all-terrain vehicles and side-by-side vehicles; snowmobiles and snow bikes conversion kit systems; motorcycles; and low emission, light duty hauling, passenger, and industrial vehicles. It also produces replacement parts and accessories comprising winches, bumper/brushguards, plows, racks, wheels and tires, pull-behinds, cab systems, lighting and audio systems, cargo box accessories, tracks, and oil for ORVs; snowmobile accessories, which comprise covers, traction products, electric starters, reverse kits, tracks, bags, windshields, oil, and lubricants; and motorcycle accessories, including e saddle bags, handlebars, backrests, exhausts, windshields, seats, oil, and various chrome accessories. In addition, the company offers gear and apparel, such as helmets, jackets, gloves, pants, hats, goggles, boots, bibs, and leathers; off-road Jeep and truck accessories; and pontoon and deck boats. The company provides its products through dealers and distributors, and online; and aftermarket parts and accessories through 95 brick-and-mortar retail centers, call centers, and e-commerce sites. The company was formerly known as Polaris Industries Inc. Polaris Inc. was founded in 1954 and is headquartered in Medina, Minnesota.
Latest EW
- CVP, TAVR Lippis Daniel J. exercised 619 shares at a strike of $72.68 and sold $56,967 worth of shares (619 units at $92.03) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form S-8 filed by Edwards Lifesciences Corporation
- SEC Form 10-Q filed by Edwards Lifesciences Corporation
- CVP, JAPAC Markowitz Wayne sold $12,588 worth of shares (146 units at $86.03), decreasing direct ownership by 0.67% to 21,534 units (SEC Form 4)
- CVP, JAPAC Markowitz Wayne exercised 9,628 shares at a strike of $74.02 and sold $818,958 worth of shares (9,628 units at $85.06) (SEC Form 4)
- UBS initiated coverage on Edwards Lifesciences with a new price target
- CEO Zovighian Bernard J gifted 320 shares, received a gift of 320 shares and sold $245,134 worth of shares (2,921 units at $83.93), decreasing direct ownership by 0.32% to 98,845 units (SEC Form 4)
- Edwards Lifesciences upgraded by Leerink Partners with a new price target
- Edwards Lifesciences Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Edwards Lifesciences Reports Second Quarter Results
Latest PII
- POLARIS RZR FACTORY RACING CONQUERS VEGAS-TO-RENO WINNING FOR THE FIRST TIME IN TEAM HISTORY
- POLARIS INTRODUCES BREAKTHROUGH POWER, INNOVATION AND VALUE ACROSS 2027 OFF-ROAD LINEUP
- Polaris Declares Regular Cash Dividend
- SEC Form S-8 filed by Polaris Inc.
- SEC Form 10-Q filed by Polaris Inc.
- Polaris Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Polaris Inc. Second Quarter 2026 Financial Results Available on Company's Website
- Polaris and Minnesota 4-H Expand Youth ATV Safety Education Through a Fun Interactive Adventure
- Polaris Schedules Second Quarter 2026 Earnings Conference Call and Webcast
- Director Kessler Bernd F was granted 531 shares, increasing direct ownership by 0.85% to 62,848 units (SEC Form 4)